Pisosterol induces interphase arrest in HL60 cells with c-MYC amplification

Area of Science:

• Cancer Biology
• Molecular Oncology
• Pharmacology

Background:

• The HL60 leukaemia cell line is a model for studying cancer cell mechanisms.
• HL60 cells exhibit c-MYC proto-oncogene amplification, leading to homogeneously staining regions (HSRs).
• c-MYC amplification is linked to aggressive cancer cell behavior.

Purpose of the Study:

• To investigate the effect of pisosterol on c-MYC gene amplification in HL60 cells.
• To evaluate pisosterol's potential as an anti-cancer therapeutic agent.

Main Methods:

• Fluorescence in situ hybridization (FISH) was used to detect c-MYC amplification.
• HL60 cells were treated with varying concentrations of pisosterol (0.5, 1.0, and 1.8 microg/mL).
• Changes in HSRs and c-MYC allele counts were quantified before and after treatment.

Main Results:

• Before treatment, 87.5% of HL60 cells displayed HSRs.
• Pisosterol at 0.5 and 1.0 microg/mL showed no significant effect.
• At 1.8 microg/mL, pisosterol reduced HSRs to 15% and increased cells with fewer c-MYC alleles (3-4) to 39.5%.

Conclusions:

• Pisosterol likely inhibits or blocks cells with high c-MYC amplification at the interphase stage.
• Reduced c-MYC amplification correlates with less aggressive cancer cell phenotypes.
• Pisosterol warrants further investigation for combination therapy with conventional anti-cancer treatments.